首页 > 最新文献

JA Clinical Reports最新文献

英文 中文
3D transesophageal echocardiographic visualization of the pulmonary artery catheter through the tricuspid valve and their position relative to the tricuspid valve leaflets. 三维经食道超声心动图显示肺动脉导管穿过三尖瓣的情况及其与三尖瓣瓣叶的相对位置。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-05-30 DOI: 10.1186/s40981-024-00718-z
Shoko Takada, Tomoko Fujimoto, Akiko Tomita-Kobayashi, Yukio Hayashi

Background: The tricuspid valve is an atrioventricular valve consisting of three lobes. We used the 3D transesophageal echocardiography to visualize position of the pulmonary artery catheter at the tricuspid valve annulus and examined where the catheter passed through at the level of the tricuspid annulus.

Methods: In this prospective and observational study, we monitored the pressure wave on patients undergoing cardiac surgery with the catheter placement by monitoring the pressure waveform for 8 months. We measured the time required for the catheter to pass through the tricuspid and pulmonary valves, respectively. We acquired the 3D image of the tricuspid valve by transesophageal echocardiography and determined the position of the pulmonary artery catheter at the level of the tricuspid annulus. The data were analyzed by Kruskal-Wallis test followed by Mann-Whitney test with Holm multiple comparisons. P < 0.05 was considered significant.

Results: Of the 116 cases, the pulmonary artery catheter passed through the tricuspid valve between antero-posterior leaflets in 78 cases (67.2 %), between septal-posterior leaflets in 25 cases (21.6 %), and between antero-septal leaflets in 2 cases (1.7 %) and the center in 11 cases (9.5 %), respectively. The time required for the catheter to pass through the pulmonary valves was significantly different among the catheter positions at the level of the tricuspid annulus.

Conclusion: The pulmonary artery catheter location at the level of the tricuspid annulus can be identified using 3D transesophageal echocardiography. The location of the catheter significantly affects the pulmonary artery catheter placement time.

背景:三尖瓣是由三叶组成的房室瓣。我们使用三维经食道超声心动图来观察肺动脉导管在三尖瓣瓣环处的位置,并检查导管在三尖瓣瓣环水平穿过的位置:在这项前瞻性观察研究中,我们对接受心脏手术并置入导管的患者进行了为期 8 个月的压力波形监测。我们分别测量了导管通过三尖瓣和肺动脉瓣所需的时间。我们通过经食道超声心动图获得了三尖瓣的三维图像,并确定了肺动脉导管在三尖瓣瓣环水平的位置。数据分析采用 Kruskal-Wallis 检验,然后进行 Mann-Whitney 检验和 Holm 多重比较。结果:在 116 例病例中,肺动脉导管穿过三尖瓣的情况分别为:前-后叶之间 78 例(67.2%)、隔-前叶之间 25 例(21.6%)、前-隔叶之间 2 例(1.7%)和中心 11 例(9.5%)。导管通过肺动脉瓣所需的时间在三尖瓣环水平的不同导管位置之间存在显著差异:结论:使用三维经食道超声心动图可确定三尖瓣环水平的肺动脉导管位置。导管位置对肺动脉导管置入时间有很大影响。
{"title":"3D transesophageal echocardiographic visualization of the pulmonary artery catheter through the tricuspid valve and their position relative to the tricuspid valve leaflets.","authors":"Shoko Takada, Tomoko Fujimoto, Akiko Tomita-Kobayashi, Yukio Hayashi","doi":"10.1186/s40981-024-00718-z","DOIUrl":"10.1186/s40981-024-00718-z","url":null,"abstract":"<p><strong>Background: </strong>The tricuspid valve is an atrioventricular valve consisting of three lobes. We used the 3D transesophageal echocardiography to visualize position of the pulmonary artery catheter at the tricuspid valve annulus and examined where the catheter passed through at the level of the tricuspid annulus.</p><p><strong>Methods: </strong>In this prospective and observational study, we monitored the pressure wave on patients undergoing cardiac surgery with the catheter placement by monitoring the pressure waveform for 8 months. We measured the time required for the catheter to pass through the tricuspid and pulmonary valves, respectively. We acquired the 3D image of the tricuspid valve by transesophageal echocardiography and determined the position of the pulmonary artery catheter at the level of the tricuspid annulus. The data were analyzed by Kruskal-Wallis test followed by Mann-Whitney test with Holm multiple comparisons. P < 0.05 was considered significant.</p><p><strong>Results: </strong>Of the 116 cases, the pulmonary artery catheter passed through the tricuspid valve between antero-posterior leaflets in 78 cases (67.2 %), between septal-posterior leaflets in 25 cases (21.6 %), and between antero-septal leaflets in 2 cases (1.7 %) and the center in 11 cases (9.5 %), respectively. The time required for the catheter to pass through the pulmonary valves was significantly different among the catheter positions at the level of the tricuspid annulus.</p><p><strong>Conclusion: </strong>The pulmonary artery catheter location at the level of the tricuspid annulus can be identified using 3D transesophageal echocardiography. The location of the catheter significantly affects the pulmonary artery catheter placement time.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"35"},"PeriodicalIF":0.9,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11139813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation. 雷马唑仑用于接受经导管主动脉瓣植入术的主动脉瓣狭窄和重度肥胖患者的全身麻醉。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-05-27 DOI: 10.1186/s40981-024-00716-1
Atsushi Kainuma, Ayaka Koyama, Mao Kinoshita, Jun Iida, Teiji Sawa

Introduction: There is currently limited research on the clinical use of remimazolam in severely obese patients. In this report, we describe the anesthesia management of transcatheter aortic valve implantation (TAVI) in a severely obese patient using remimazolam.

Case description: A 76-year-old woman (height 1.54 m; total body weight 104 kg; body mass index 43.9 kg/m2) was scheduled for TAVI via the femoral artery approach for aortic valve stenosis. Preoperative echocardiography showed an aortic valve peak flow of 4.0 m/s and an effective orifice area of 0.75 cm2. Anesthesia induction was performed with a bolus dose of 100 μg fentanyl, 15 mg remimazolam, 60 mg rocuronium, and a continuous infusion of remifentanil at 0.4 mg/h. Intraoperatively, remimazolam was administered at a rate of 35 mg/h. General anesthesia management was completed without any complications, although the patient required temporary catecholamine and inhalation anesthesia assistance due to hemodynamic changes.

Conclusion: Owing to its pharmacological advantages, remimazolam may be an option for anesthesia induction and maintenance in severely obese patients with unstable circulation.

简介:目前,关于重度肥胖患者使用雷马唑仑的临床研究十分有限。在本报告中,我们介绍了使用雷马唑仑对重度肥胖患者进行经导管主动脉瓣植入术(TAVI)的麻醉管理:一名 76 岁的妇女(身高 1.54 米;总重量 104 千克;体重指数 43.9 千克/平方米)因主动脉瓣狭窄而计划通过股动脉途径进行 TAVI。术前超声心动图显示主动脉瓣峰值流量为 4.0 m/s,有效瓣口面积为 0.75 cm2。麻醉诱导采用100微克芬太尼、15毫克瑞咪唑仑、60毫克罗库溴铵和0.4毫克/小时的瑞芬太尼持续输注。术中使用的瑞马唑仑剂量为 35 毫克/小时。虽然患者因血流动力学变化而需要临时的儿茶酚胺和吸入麻醉辅助,但全身麻醉管理顺利完成,未出现任何并发症:结论:由于其药理优势,雷马唑仑可作为血液循环不稳定的重度肥胖患者麻醉诱导和维持的一种选择。
{"title":"Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation.","authors":"Atsushi Kainuma, Ayaka Koyama, Mao Kinoshita, Jun Iida, Teiji Sawa","doi":"10.1186/s40981-024-00716-1","DOIUrl":"10.1186/s40981-024-00716-1","url":null,"abstract":"<p><strong>Introduction: </strong>There is currently limited research on the clinical use of remimazolam in severely obese patients. In this report, we describe the anesthesia management of transcatheter aortic valve implantation (TAVI) in a severely obese patient using remimazolam.</p><p><strong>Case description: </strong>A 76-year-old woman (height 1.54 m; total body weight 104 kg; body mass index 43.9 kg/m<sup>2</sup>) was scheduled for TAVI via the femoral artery approach for aortic valve stenosis. Preoperative echocardiography showed an aortic valve peak flow of 4.0 m/s and an effective orifice area of 0.75 cm<sup>2</sup>. Anesthesia induction was performed with a bolus dose of 100 μg fentanyl, 15 mg remimazolam, 60 mg rocuronium, and a continuous infusion of remifentanil at 0.4 mg/h. Intraoperatively, remimazolam was administered at a rate of 35 mg/h. General anesthesia management was completed without any complications, although the patient required temporary catecholamine and inhalation anesthesia assistance due to hemodynamic changes.</p><p><strong>Conclusion: </strong>Owing to its pharmacological advantages, remimazolam may be an option for anesthesia induction and maintenance in severely obese patients with unstable circulation.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"34"},"PeriodicalIF":0.9,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141154464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive model for post-induction hypotension in patients undergoing transcatheter aortic valve implantation: a retrospective observational study. 经导管主动脉瓣植入术患者诱导后低血压的预测模型:一项回顾性观察研究。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-05-24 DOI: 10.1186/s40981-024-00717-0
Kohei Noto, Satoshi Uchida, Hirotaka Kinoshita, Daiki Takekawa, Tetsuya Kushikata, Kazuyoshi Hirota

Purpose: Post-induction hypotension (PIH) is an independent risk factor for prolonged postoperative stay and hospital death. Patients undergoing transcatheter aortic valve implantation (TAVI) are prone to develop PIH. This study aimed to develop a predictive model for PIH in patients undergoing TAVI.

Methods: This single-center retrospective observational study included 163 patients who underwent TAVI. PIH was defined as at least one measurement of systolic arterial pressure <90 mmHg or at least one incident of norepinephrine infusion at a rate >6 µg/min from anesthetic induction until 20 min post-induction. Multivariate logistic regression analysis was performed to develop a predictive model for PIH in patients undergoing TAVI.

Results: In total, 161 patients were analyzed. The prevalence of PIH was 57.8%. Multivariable logistic regression analysis showed that baseline mean arterial pressure ≥90 mmHg [adjusted odds ratio (aOR): 0.413, 95% confidence interval (95% CI): 0.193-0.887; p=0.023] and higher doses of fentanyl (per 1-µg/kg increase, aOR: 0.619, 95% CI: 0.418-0.915; p=0.016) and ketamine (per 1-mg/kg increase, aOR: 0.163, 95% CI: 0.062-0.430; p=0.002) for induction were significantly associated with lower risk of PIH. A higher dose of propofol (per 1-mg/kg increase, aOR: 3.240, 95% CI: 1.320-7.920; p=0.010) for induction was significantly associated with higher risk of PIH. The area under the curve (AUC) for this model was 0.802.

Conclusion: The present study developed predictive models for PIH in patients who underwent TAVI. This model may be helpful for anesthesiologists in preventing PIH in patients undergoing TAVI.

目的:诱导后低血压(PIH)是导致术后住院时间延长和住院死亡的独立风险因素。接受经导管主动脉瓣植入术(TAVI)的患者很容易出现 PIH。本研究旨在建立经导管主动脉瓣植入术患者 PIH 的预测模型:这项单中心回顾性观察研究纳入了 163 名接受 TAVI 的患者。PIH定义为从麻醉诱导到诱导后20分钟内至少有一次测量到收缩压为6 µg/min。进行了多变量逻辑回归分析,以建立TAVI患者PIH的预测模型:结果:共分析了 161 例患者。结果:共分析了 161 名患者,PIH 发生率为 57.8%。多变量逻辑回归分析显示,基线平均动脉压≥90 mmHg [调整赔率(aOR):0.413,95% 置信区间(95% CI):0.193-0.887;P=0.023]以及诱导时使用较高剂量的芬太尼(每增加 1-µg/kg,aOR:0.619,95% CI:0.418-0.915;p=0.016)和氯胺酮(每增加 1-mg/kg,aOR:0.163,95% CI:0.062-0.430;p=0.002)与较低的 PIH 风险显著相关。诱导时使用较高剂量的异丙酚(每增加 1 毫克/千克,aOR:3.240,95% CI:1.320-7.920;p=0.010)与较高的 PIH 风险显著相关。该模型的曲线下面积(AUC)为 0.802:本研究建立了TAVI患者PIH的预测模型。结论:本研究建立了 TAVI 患者 PIH 的预测模型,该模型可能有助于麻醉医师预防 TAVI 患者的 PIH。
{"title":"Predictive model for post-induction hypotension in patients undergoing transcatheter aortic valve implantation: a retrospective observational study.","authors":"Kohei Noto, Satoshi Uchida, Hirotaka Kinoshita, Daiki Takekawa, Tetsuya Kushikata, Kazuyoshi Hirota","doi":"10.1186/s40981-024-00717-0","DOIUrl":"10.1186/s40981-024-00717-0","url":null,"abstract":"<p><strong>Purpose: </strong>Post-induction hypotension (PIH) is an independent risk factor for prolonged postoperative stay and hospital death. Patients undergoing transcatheter aortic valve implantation (TAVI) are prone to develop PIH. This study aimed to develop a predictive model for PIH in patients undergoing TAVI.</p><p><strong>Methods: </strong>This single-center retrospective observational study included 163 patients who underwent TAVI. PIH was defined as at least one measurement of systolic arterial pressure <90 mmHg or at least one incident of norepinephrine infusion at a rate >6 µg/min from anesthetic induction until 20 min post-induction. Multivariate logistic regression analysis was performed to develop a predictive model for PIH in patients undergoing TAVI.</p><p><strong>Results: </strong>In total, 161 patients were analyzed. The prevalence of PIH was 57.8%. Multivariable logistic regression analysis showed that baseline mean arterial pressure ≥90 mmHg [adjusted odds ratio (aOR): 0.413, 95% confidence interval (95% CI): 0.193-0.887; p=0.023] and higher doses of fentanyl (per 1-µg/kg increase, aOR: 0.619, 95% CI: 0.418-0.915; p=0.016) and ketamine (per 1-mg/kg increase, aOR: 0.163, 95% CI: 0.062-0.430; p=0.002) for induction were significantly associated with lower risk of PIH. A higher dose of propofol (per 1-mg/kg increase, aOR: 3.240, 95% CI: 1.320-7.920; p=0.010) for induction was significantly associated with higher risk of PIH. The area under the curve (AUC) for this model was 0.802.</p><p><strong>Conclusion: </strong>The present study developed predictive models for PIH in patients who underwent TAVI. This model may be helpful for anesthesiologists in preventing PIH in patients undergoing TAVI.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"33"},"PeriodicalIF":0.9,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of pediatric Perthes' disease with unexplained hyperlactatemia at the time of initial surgery and anesthetic management with remimazolam for the subsequent surgery. 一例小儿珀尔特氏病患者在初次手术时出现不明原因的高乳酸血症,并在随后的手术中使用了瑞马唑仑进行麻醉处理。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-05-24 DOI: 10.1186/s40981-024-00715-2
Ko Ishikawa, Tadanao Hiroki, Sachiko Ito, Chizu Aso, Shigeru Saito

Background: The causes of perioperative hyperlactatemia vary, but they are generally associated with hypoperfusion. Here, we report the case of a pediatric patient who developed unexplained hyperlactatemia during anesthesia with propofol and sevoflurane, which recurred during a second surgery under anesthesia with remimazolam.

Case presentation: An 8-year-old boy with Perthes disease and no remarkable past or family history was scheduled for an osteotomy. Anesthesia was induced with propofol and rocuronium and then maintained with sevoflurane and remifentanil. The patient developed lactic acidosis without hemodynamic instability during anesthesia, with a normal lactate/pyruvate ratio after surgery, suggesting a lack of hypoperfusion. We used remimazolam instead of propofol during the second surgery 6 months later, considering the possibility of drug-induced lactic acidosis, including malignant hyperthermia and propofol infusion syndrome, where the unexplained hyperlactatemia recurred.

Conclusions: Distinguishing the causes of hyperlactatemia, particularly in the absence of other symptoms, is challenging. The lactate/pyruvate ratio during episodes of hyperlactatemia can provide insights into the underlying pathology.

背景:围术期高乳酸血症的原因各不相同,但一般都与低灌注有关。在此,我们报告了一例小儿患者在使用异丙酚和七氟醚麻醉期间出现不明原因的高乳酸血症,并在使用瑞马唑仑麻醉的第二次手术中复发:一名患有珀尔特氏病的 8 岁男孩,无明显既往史或家族史,计划接受截骨手术。使用丙泊酚和罗库溴铵诱导麻醉,然后使用七氟醚和瑞芬太尼维持麻醉。患者在麻醉过程中出现乳酸酸中毒,但血流动力学并不稳定,术后乳酸/丙酮酸比值正常,表明没有灌注不足。考虑到药物诱发乳酸酸中毒的可能性,包括恶性高热和异丙酚输注综合征,我们在6个月后的第二次手术中使用了瑞马唑仑而不是异丙酚,结果不明原因的高乳酸血症再次出现:结论:区分高乳酸血症的病因具有挑战性,尤其是在没有其他症状的情况下。高乳酸血症发作时的乳酸/丙酮酸比值可帮助我们了解潜在的病理原因。
{"title":"A case of pediatric Perthes' disease with unexplained hyperlactatemia at the time of initial surgery and anesthetic management with remimazolam for the subsequent surgery.","authors":"Ko Ishikawa, Tadanao Hiroki, Sachiko Ito, Chizu Aso, Shigeru Saito","doi":"10.1186/s40981-024-00715-2","DOIUrl":"10.1186/s40981-024-00715-2","url":null,"abstract":"<p><strong>Background: </strong>The causes of perioperative hyperlactatemia vary, but they are generally associated with hypoperfusion. Here, we report the case of a pediatric patient who developed unexplained hyperlactatemia during anesthesia with propofol and sevoflurane, which recurred during a second surgery under anesthesia with remimazolam.</p><p><strong>Case presentation: </strong>An 8-year-old boy with Perthes disease and no remarkable past or family history was scheduled for an osteotomy. Anesthesia was induced with propofol and rocuronium and then maintained with sevoflurane and remifentanil. The patient developed lactic acidosis without hemodynamic instability during anesthesia, with a normal lactate/pyruvate ratio after surgery, suggesting a lack of hypoperfusion. We used remimazolam instead of propofol during the second surgery 6 months later, considering the possibility of drug-induced lactic acidosis, including malignant hyperthermia and propofol infusion syndrome, where the unexplained hyperlactatemia recurred.</p><p><strong>Conclusions: </strong>Distinguishing the causes of hyperlactatemia, particularly in the absence of other symptoms, is challenging. The lactate/pyruvate ratio during episodes of hyperlactatemia can provide insights into the underlying pathology.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"31"},"PeriodicalIF":0.9,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment-resistant hiccups during general anesthesia possibly caused by remimazolam: a case report. 可能由瑞咪唑安定引起的全身麻醉期间的治疗抵抗性打嗝:一份病例报告。
IF 0.8 Q3 ANESTHESIOLOGY Pub Date : 2024-05-24 DOI: 10.1186/s40981-024-00714-3
Miku Sakurai, Yusuke Matsui, Tomonori Takazawa, Yoji Kabasawa, Wataru Nagumo, Ryo Takada, Shigeru Saito

Background: Previous reports have described hiccups during general anesthesia that were possibly induced by drugs, including benzodiazepines. However, there are few reports of hiccups caused by remimazolam. Case presentation A 75-year-old woman underwent corneal transplantation under general anesthesia with remimazolam. She presented with hiccups once the effects of muscle relaxants used during induction wore off, which persisted even after various treatments, such as the administration of antipsychotic drugs. However, when remimazolam administration was terminated after surgery to awaken the patient, the hiccups stopped and did not recur after extubation. Evaluation of predicted blood levels of remimazolam suggests that higher levels of remimazolam might cause hiccups.

Conclusion: Remimazolam might induce hiccups during general anesthesia. Anesthesiologists should consider administering muscle relaxants or changing the anesthetic in cases of refractory hiccups under general anesthesia.

背景:以前的报告曾描述过全身麻醉期间可能由药物(包括苯二氮卓类药物)诱发的打嗝。然而,有关雷马唑仑引起打嗝的报道却很少。病例介绍 一位 75 岁的妇女在使用雷马唑仑的全身麻醉下接受了角膜移植手术。诱导过程中使用的肌肉松弛剂药效一过,她就出现了打嗝的症状,即使经过各种治疗(如服用抗精神病药物),这种症状依然存在。然而,当手术后终止使用雷马唑仑以唤醒病人时,打嗝停止了,拔管后也没有再出现。对预测的雷马唑仑血药浓度的评估表明,较高浓度的雷马唑仑可能会导致打嗝:结论:雷美唑仑可能会在全身麻醉期间诱发打嗝。结论:雷美唑仑可能会在全身麻醉过程中诱发打嗝,麻醉师应考虑在全身麻醉过程中使用肌肉松弛剂或更换麻醉药。
{"title":"Treatment-resistant hiccups during general anesthesia possibly caused by remimazolam: a case report.","authors":"Miku Sakurai, Yusuke Matsui, Tomonori Takazawa, Yoji Kabasawa, Wataru Nagumo, Ryo Takada, Shigeru Saito","doi":"10.1186/s40981-024-00714-3","DOIUrl":"10.1186/s40981-024-00714-3","url":null,"abstract":"<p><strong>Background: </strong>Previous reports have described hiccups during general anesthesia that were possibly induced by drugs, including benzodiazepines. However, there are few reports of hiccups caused by remimazolam. Case presentation A 75-year-old woman underwent corneal transplantation under general anesthesia with remimazolam. She presented with hiccups once the effects of muscle relaxants used during induction wore off, which persisted even after various treatments, such as the administration of antipsychotic drugs. However, when remimazolam administration was terminated after surgery to awaken the patient, the hiccups stopped and did not recur after extubation. Evaluation of predicted blood levels of remimazolam suggests that higher levels of remimazolam might cause hiccups.</p><p><strong>Conclusion: </strong>Remimazolam might induce hiccups during general anesthesia. Anesthesiologists should consider administering muscle relaxants or changing the anesthetic in cases of refractory hiccups under general anesthesia.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"32"},"PeriodicalIF":0.8,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting. 一项关于术前活化部分凝血活酶时间个别延长发生率的回顾性研究。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-05-07 DOI: 10.1186/s40981-024-00713-4
Yasuhiro Watanabe, Yuki Kato, Takayuki Matsuno

Background: Isolated prolongation of activated partial thromboplastin time (APTT) has various causes including inheritable bleeding disorders, and has medical significance as it can lead to the cancelation of surgery. However, even an emergency surgery can be conducted in a patient presenting with severe APTT prolongation, provided careful evaluation and appropriate measures are taken. Hence, the identification of the underlying etiology of the prolonged APTT is crucial. To date, little evidence exists regarding the prevalence of isolated APTT prolongation in Japanese patients undergoing surgery. Herein, we aimed to clarify the prevalence of isolated prolongation of APTT in the preoperative setting and to identify the reasons underlying isolated, severely prolonged APTT.

Methods: Preoperative coagulation data of all elective and emergent patients who presented to the anesthetic department between January 1, 2020, and June 30, 2023, were retrospectively collected. Isolated prolongation of APTT was defined as an APTT ≥ 37 s with an international normalized ratio of prothrombin time < 1.2. The underlying etiology of the patient with isolated, severely prolonged APTT (≥ 46 s) was investigated, and canceled surgical procedures in relation to the isolated APTT prolongation were searched.

Results: Overall, 10,684 measurements from 9413 patients were included, of which 725 (6.8%) were identified as having isolated APTT prolongation. The reasons for the severely prolonged APTT (n = 60) were miscellaneous, with the most frequently detected etiology being antiphospholipid antibody positivity. Preoperative isolated APTT prolongation contributed to the cancellation of surgery in elective five cases.

Conclusions: We clarified the prevalence of preoperative isolated prolongation of APTT. The presence of antiphospholipid antibody was the most frequently detected etiology of the patient with isolated, severely prolonged APTT. The present study provides an important dataset regarding the isolated prolongation of APTT in East Asian patients undergoing surgery.

背景:孤立的活化部分凝血活酶时间(APTT)延长有多种原因,包括遗传性出血性疾病。然而,只要仔细评估并采取适当措施,即使是出现严重 APTT 延长的患者,也可以进行急诊手术。因此,确定 APTT 延长的潜在病因至关重要。迄今为止,关于接受手术的日本患者发生孤立性 APTT 延长的证据还很少。在此,我们旨在明确术前环境中孤立性 APTT 延长的发生率,并找出导致孤立性 APTT 严重延长的原因:方法:回顾性收集了 2020 年 1 月 1 日至 2023 年 6 月 30 日期间麻醉科所有择期手术和急诊患者的术前凝血数据。APTT 单独延长的定义是 APTT ≥ 37 秒,且凝血酶原时间的国际标准化比值结果:共纳入了 9413 名患者的 10684 次测量结果,其中 725 次(6.8%)被确定为孤立性 APTT 延长。APTT 严重延长(n = 60)的原因多种多样,最常见的病因是抗磷脂抗体阳性。术前孤立性 APTT 延长导致 5 例择期手术被取消:我们明确了术前孤立性 APTT 延长的发生率。抗磷脂抗体是孤立性 APTT 严重延长患者最常见的病因。本研究为东亚手术患者的孤立性 APTT 延长提供了一个重要的数据集。
{"title":"A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting.","authors":"Yasuhiro Watanabe, Yuki Kato, Takayuki Matsuno","doi":"10.1186/s40981-024-00713-4","DOIUrl":"10.1186/s40981-024-00713-4","url":null,"abstract":"<p><strong>Background: </strong>Isolated prolongation of activated partial thromboplastin time (APTT) has various causes including inheritable bleeding disorders, and has medical significance as it can lead to the cancelation of surgery. However, even an emergency surgery can be conducted in a patient presenting with severe APTT prolongation, provided careful evaluation and appropriate measures are taken. Hence, the identification of the underlying etiology of the prolonged APTT is crucial. To date, little evidence exists regarding the prevalence of isolated APTT prolongation in Japanese patients undergoing surgery. Herein, we aimed to clarify the prevalence of isolated prolongation of APTT in the preoperative setting and to identify the reasons underlying isolated, severely prolonged APTT.</p><p><strong>Methods: </strong>Preoperative coagulation data of all elective and emergent patients who presented to the anesthetic department between January 1, 2020, and June 30, 2023, were retrospectively collected. Isolated prolongation of APTT was defined as an APTT ≥ 37 s with an international normalized ratio of prothrombin time < 1.2. The underlying etiology of the patient with isolated, severely prolonged APTT (≥ 46 s) was investigated, and canceled surgical procedures in relation to the isolated APTT prolongation were searched.</p><p><strong>Results: </strong>Overall, 10,684 measurements from 9413 patients were included, of which 725 (6.8%) were identified as having isolated APTT prolongation. The reasons for the severely prolonged APTT (n = 60) were miscellaneous, with the most frequently detected etiology being antiphospholipid antibody positivity. Preoperative isolated APTT prolongation contributed to the cancellation of surgery in elective five cases.</p><p><strong>Conclusions: </strong>We clarified the prevalence of preoperative isolated prolongation of APTT. The presence of antiphospholipid antibody was the most frequently detected etiology of the patient with isolated, severely prolonged APTT. The present study provides an important dataset regarding the isolated prolongation of APTT in East Asian patients undergoing surgery.</p>","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"10 1","pages":"30"},"PeriodicalIF":0.9,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11076442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between perioperative non-steroidal anti-inflammatory drug use and cardiovascular complications after non-cardiac surgery in older adult patients 老年患者非心脏手术后围术期使用非甾体抗炎药与心血管并发症之间的关系
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-04-30 DOI: 10.1186/s40981-024-00712-5
Ryu Komatsu, Michael D. Singleton, Emily M. Dinges, Jiang Wu, Laurent A. Bollag
We investigated in older adult non-cardiac surgical patients whether receipt of perioperative non-steroidal anti-inflammatory drugs (NSAIDs) is associated with increased incidence of postoperative cardiovascular complications. We retrospectively extracted the information for patients with age ≥ 65 years who had inpatient non-cardiac surgery with a duration of ≥ 1 h from the American College of Surgeons-National Surgical Quality Improvement Program registry data acquired at the University of Washington Medical Center. We compared patients who received NSAIDs perioperatively to those who did not receive NSAIDs, on the two composite outcomes: (1) the incidence of postoperative cardiovascular complications within 30 days of the surgery, and (2) the incidence of combined postoperative gastrointestinal and renal complications, and length of postoperative hospital stay. We used separate multivariable logistic regression models to analyze the two composite outcomes and a Poisson regression model for the length of hospital stay. The receipt of perioperative NSAIDs was not associated with postoperative cardiovascular complications (estimated odds ratio (OR), 1.78; 95% confidence interval (CI), 0.97 to 3.25; P = 0.06), combined renal and gastrointestinal complications (estimated OR, 1.30; 95% CI, 0.53 to 3.20; P = 0.57), and length of postoperative hospital stay in days (incidence rate ratio, 1.06; 95% CI, 0.93 to 1.21; P = 0.39). In older adult non-cardiac surgical patients, receipt of perioperative NSAIDs was not associated with increased incidences of postoperative cardiovascular complications, and renal and gastrointestinal complications within 30 days after surgery, or length of postoperative hospital stay.
我们研究了老年非心脏手术患者围手术期服用非甾体抗炎药(NSAIDs)是否与术后心血管并发症发生率增加有关。我们从华盛顿大学医学中心获得的美国外科学院-国家外科质量改进计划登记数据中回顾性地提取了年龄≥ 65 岁、住院非心脏手术时间≥ 1 小时的患者信息。我们比较了围手术期服用非甾体抗炎药和未服用非甾体抗炎药的患者在以下两个方面的综合结果:(1) 术后 30 天内心血管并发症的发生率;(2) 术后胃肠道和肾脏并发症的发生率以及术后住院时间。我们分别使用多变量逻辑回归模型来分析这两种综合结果,并使用泊松回归模型来分析住院时间。围手术期服用非甾体抗炎药与术后心血管并发症(估计比值比 (OR),1.78;95% 置信区间 (CI),0.97-3.25;P = 0.06)、合并肾脏和胃肠道并发症(估计 OR,1.30;95% CI,0.53 至 3.20;P = 0.57)以及术后住院天数(发病率比,1.06;95% CI,0.93 至 1.21;P = 0.39)。在老年非心脏手术患者中,围手术期服用非甾体抗炎药与术后心血管并发症、术后30天内肾脏和胃肠道并发症发生率的增加以及术后住院时间的延长无关。
{"title":"Association between perioperative non-steroidal anti-inflammatory drug use and cardiovascular complications after non-cardiac surgery in older adult patients","authors":"Ryu Komatsu, Michael D. Singleton, Emily M. Dinges, Jiang Wu, Laurent A. Bollag","doi":"10.1186/s40981-024-00712-5","DOIUrl":"https://doi.org/10.1186/s40981-024-00712-5","url":null,"abstract":"We investigated in older adult non-cardiac surgical patients whether receipt of perioperative non-steroidal anti-inflammatory drugs (NSAIDs) is associated with increased incidence of postoperative cardiovascular complications. We retrospectively extracted the information for patients with age ≥ 65 years who had inpatient non-cardiac surgery with a duration of ≥ 1 h from the American College of Surgeons-National Surgical Quality Improvement Program registry data acquired at the University of Washington Medical Center. We compared patients who received NSAIDs perioperatively to those who did not receive NSAIDs, on the two composite outcomes: (1) the incidence of postoperative cardiovascular complications within 30 days of the surgery, and (2) the incidence of combined postoperative gastrointestinal and renal complications, and length of postoperative hospital stay. We used separate multivariable logistic regression models to analyze the two composite outcomes and a Poisson regression model for the length of hospital stay. The receipt of perioperative NSAIDs was not associated with postoperative cardiovascular complications (estimated odds ratio (OR), 1.78; 95% confidence interval (CI), 0.97 to 3.25; P = 0.06), combined renal and gastrointestinal complications (estimated OR, 1.30; 95% CI, 0.53 to 3.20; P = 0.57), and length of postoperative hospital stay in days (incidence rate ratio, 1.06; 95% CI, 0.93 to 1.21; P = 0.39). In older adult non-cardiac surgical patients, receipt of perioperative NSAIDs was not associated with increased incidences of postoperative cardiovascular complications, and renal and gastrointestinal complications within 30 days after surgery, or length of postoperative hospital stay.","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"48 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140841995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remimazolam-based total intravenous anesthesia in a patient with a confirmed diagnosis of malignant hyperthermia: a case report 在一名确诊为恶性高热的患者中使用基于雷马唑仑的全静脉麻醉:病例报告
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-04-22 DOI: 10.1186/s40981-024-00710-7
Hiroshi Kondo, Keiko Mukaida, Kurumi Sasai, Yukiko Nao, Ken Hashimoto, Hirotsugu Miyoshi, Rieko Kanzaki, Yasuo M. Tsutsumi
Malignant hyperthermia (MH) is a rare, life-threatening disorder of calcium homeostasis in skeletal muscle cells that is triggered by volatile anesthetics and succinylcholine, leading to a hypermetabolic reaction. The pathogenic ryanodine receptor 1 (RYR1) gene variant is critical. Patients susceptible to MH should avoid triggering agents, and total intravenous anesthesia (TIVA) is preferred. Remimazolam is safe in patients with suspected MH. We present the first case of remimazolam treatment in a genetically confirmed patient with MH without MH development. A 72-year-old man with a family history of MH underwent remimazolam-based TIVA. After informed consent was obtained, a muscle biopsy and genetic testing were performed. Intraoperatively and postoperatively, the patient exhibited no signs of MH. An enhanced function of the RYR1 channel into releasing calcium was indicated, and the genetic testing revealed a pathogenic variant of RYR1. Remimazolam-based TIVA is safe in patients confirming the diagnosis of MH.
恶性高热(MH)是一种罕见的、危及生命的骨骼肌细胞钙平衡失调症,由挥发性麻醉剂和琥珀胆碱引发,导致高代谢反应。致病的雷诺丁受体 1(RYR1)基因变异至关重要。对 MH 易感的患者应避免使用触发剂,最好采用全静脉麻醉(TIVA)。雷米马唑仑对疑似 MH 患者是安全的。我们介绍了首例经基因证实患有 MH 但未发展为 MH 的患者接受雷美马唑仑治疗的病例。一名有 MH 家族史的 72 岁男性接受了基于雷马唑仑的 TIVA 治疗。在获得知情同意后,进行了肌肉活检和基因检测。术中和术后,患者均未表现出 MH 征兆。RYR1 通道释放钙的功能增强,基因检测显示 RYR1 存在致病变异。在确诊为 MH 的患者中,基于雷马唑仑的 TIVA 是安全的。
{"title":"Remimazolam-based total intravenous anesthesia in a patient with a confirmed diagnosis of malignant hyperthermia: a case report","authors":"Hiroshi Kondo, Keiko Mukaida, Kurumi Sasai, Yukiko Nao, Ken Hashimoto, Hirotsugu Miyoshi, Rieko Kanzaki, Yasuo M. Tsutsumi","doi":"10.1186/s40981-024-00710-7","DOIUrl":"https://doi.org/10.1186/s40981-024-00710-7","url":null,"abstract":"Malignant hyperthermia (MH) is a rare, life-threatening disorder of calcium homeostasis in skeletal muscle cells that is triggered by volatile anesthetics and succinylcholine, leading to a hypermetabolic reaction. The pathogenic ryanodine receptor 1 (RYR1) gene variant is critical. Patients susceptible to MH should avoid triggering agents, and total intravenous anesthesia (TIVA) is preferred. Remimazolam is safe in patients with suspected MH. We present the first case of remimazolam treatment in a genetically confirmed patient with MH without MH development. A 72-year-old man with a family history of MH underwent remimazolam-based TIVA. After informed consent was obtained, a muscle biopsy and genetic testing were performed. Intraoperatively and postoperatively, the patient exhibited no signs of MH. An enhanced function of the RYR1 channel into releasing calcium was indicated, and the genetic testing revealed a pathogenic variant of RYR1. Remimazolam-based TIVA is safe in patients confirming the diagnosis of MH.","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"139 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140636356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthetic management in pregnant women with Fontan circulation: a case series 方坦循环孕妇的麻醉管理:病例系列
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-04-18 DOI: 10.1186/s40981-024-00706-3
Ai Fujita, Kazuhiro Shirozu, Midoriko Higashi, Ken Yamaura
Given the advances in medicine, women with Fontan circulation are now reaching childbearing age. However, data on the mode of delivery and anesthetic management of these patients are limited. We report the cases of five pregnant women with Fontan circulation. The mean age at delivery was 28 ± 3 years, and the mean gestational period was 34 weeks and 3 days. Anticoagulation therapy was switched from warfarin and aspirin to continuous intravenous heparin. The modes of delivery were scheduled cesarean section (C/S) in one, emergency C/S in three, and vaginal delivery with epidural labor analgesia in one patient. Three patients underwent C/S under regional anesthesia; one received general anesthesia. The perinatal complications were heart failure, worsening valve regurgitation, and postoperative hematoma in three, four, and two patients, respectively. For C/S in women with Fontan circulation, regional anesthesia should be considered. Epidural labor analgesia can help prevent the decrease in pulmonary blood flow due to straining. We initiated labor analgesia or C/S with regional anesthesia at the appropriate time in four patients.
随着医学的进步,患有丰坦循环的女性如今已步入生育年龄。然而,有关这些患者的分娩方式和麻醉管理的数据却很有限。我们报告了五名患有丰唐循环的孕妇的病例。她们的平均分娩年龄为28±3岁,平均孕期为34周零3天。抗凝治疗从华法林和阿司匹林改为持续静脉注射肝素。1名患者的分娩方式为计划剖宫产(C/S),3名患者为紧急剖宫产,1名患者为阴道分娩加硬膜外分娩镇痛。三名患者在区域麻醉下进行了剖腹产,一名患者接受了全身麻醉。围产期并发症分别为3例、4例和2例患者出现心力衰竭、瓣膜返流恶化和术后血肿。对于患有丰坦循环的产妇进行剖宫产手术,应考虑采用区域麻醉。硬膜外分娩镇痛有助于防止因用力导致的肺血流减少。我们在四例患者中适时使用了分娩镇痛或区域麻醉进行剖宫产术。
{"title":"Anesthetic management in pregnant women with Fontan circulation: a case series","authors":"Ai Fujita, Kazuhiro Shirozu, Midoriko Higashi, Ken Yamaura","doi":"10.1186/s40981-024-00706-3","DOIUrl":"https://doi.org/10.1186/s40981-024-00706-3","url":null,"abstract":"Given the advances in medicine, women with Fontan circulation are now reaching childbearing age. However, data on the mode of delivery and anesthetic management of these patients are limited. We report the cases of five pregnant women with Fontan circulation. The mean age at delivery was 28 ± 3 years, and the mean gestational period was 34 weeks and 3 days. Anticoagulation therapy was switched from warfarin and aspirin to continuous intravenous heparin. The modes of delivery were scheduled cesarean section (C/S) in one, emergency C/S in three, and vaginal delivery with epidural labor analgesia in one patient. Three patients underwent C/S under regional anesthesia; one received general anesthesia. The perinatal complications were heart failure, worsening valve regurgitation, and postoperative hematoma in three, four, and two patients, respectively. For C/S in women with Fontan circulation, regional anesthesia should be considered. Epidural labor analgesia can help prevent the decrease in pulmonary blood flow due to straining. We initiated labor analgesia or C/S with regional anesthesia at the appropriate time in four patients.","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"140 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140630037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthesia management of laparoscopic right colectomy in an older patient with postoperative tetralogy of Fallot with residual anomaly 法洛氏四联症术后残留畸形老年患者腹腔镜右结肠切除术的麻醉管理
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-04-11 DOI: 10.1186/s40981-024-00707-2
Satori Mori, Hisakatsu Ito, Sadamu Sugimoto, Daisuke Hibi, Akiyo Kameyama, Masaaki Kawakami, Tomonori Takazawa
Diversity in hemodynamics of adult congenital heart disease necessitates a case-by-case selection of appropriate surgical and anesthetic options. However, previous case reports regarding the management of laparoscopic surgery in adult patients with congenital heart disease are limited. A 72-year-old man who underwent a laparoscopic right colectomy for colon cancer had a residual ventricular septal defect and right ventricular outflow tract obstruction despite post-repair of tetralogy of Fallot. Pulmonary hypertension or right ventricular dysfunction was not observed. The preoperative pulmonary to systemic blood flow ratio (Qp/Qs) was 2.3. After positive pressure ventilation and insufflation, the amount of left-to-right ventricular shunting decreased, and the Qp/Qs approached 1.0, as calculated from pulmonary arterial and systemic arterial blood gas analysis. Laparoscopic surgery might be tolerable in patients with tetralogy of Fallot who have preserved the right ventricular function, left-to-right ventricular shunting, and no high pulmonary vascular resistance.
成人先天性心脏病的血流动力学各不相同,因此需要根据具体情况选择合适的手术和麻醉方案。然而,以往关于先天性心脏病成人患者腹腔镜手术治疗的病例报告非常有限。一名 72 岁的男性因结肠癌接受了腹腔镜右结肠切除术,尽管他的法洛氏四联症已经修复,但他仍有残留的室间隔缺损和右室流出道梗阻。未观察到肺动脉高压或右心室功能障碍。术前肺血流与全身血流之比(Qp/Qs)为 2.3。经过正压通气和充气后,左心室与右心室的分流量减少,根据肺动脉和全身动脉血气分析计算,Qp/Qs接近1.0。对于保留右心室功能、左至右心室分流、肺血管阻力不高的法洛四联症患者来说,腹腔镜手术可能是可以忍受的。
{"title":"Anesthesia management of laparoscopic right colectomy in an older patient with postoperative tetralogy of Fallot with residual anomaly","authors":"Satori Mori, Hisakatsu Ito, Sadamu Sugimoto, Daisuke Hibi, Akiyo Kameyama, Masaaki Kawakami, Tomonori Takazawa","doi":"10.1186/s40981-024-00707-2","DOIUrl":"https://doi.org/10.1186/s40981-024-00707-2","url":null,"abstract":"Diversity in hemodynamics of adult congenital heart disease necessitates a case-by-case selection of appropriate surgical and anesthetic options. However, previous case reports regarding the management of laparoscopic surgery in adult patients with congenital heart disease are limited. A 72-year-old man who underwent a laparoscopic right colectomy for colon cancer had a residual ventricular septal defect and right ventricular outflow tract obstruction despite post-repair of tetralogy of Fallot. Pulmonary hypertension or right ventricular dysfunction was not observed. The preoperative pulmonary to systemic blood flow ratio (Qp/Qs) was 2.3. After positive pressure ventilation and insufflation, the amount of left-to-right ventricular shunting decreased, and the Qp/Qs approached 1.0, as calculated from pulmonary arterial and systemic arterial blood gas analysis. Laparoscopic surgery might be tolerable in patients with tetralogy of Fallot who have preserved the right ventricular function, left-to-right ventricular shunting, and no high pulmonary vascular resistance.","PeriodicalId":14635,"journal":{"name":"JA Clinical Reports","volume":"20 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140576091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JA Clinical Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1